Skip to content

Commit

Permalink
Update compilation
Browse files Browse the repository at this point in the history
  • Loading branch information
@cthoyt
cthoyt committed Jul 1, 2019
1 parent 2bc9e8c commit 2a32cc7
Show file tree
Hide file tree
Showing 28 changed files with 110,013 additions and 49,761 deletions.
188 changes: 124 additions & 64 deletions hbp_knowledge/antalarmin/alderman2018.bel.json
View file

Large diffs are not rendered by default.

231 changes: 189 additions & 42 deletions hbp_knowledge/antalarmin/lewis1996.bel.json
View file
Original file line number Diff line number Diff line change
Expand Up @@ -67,6 +67,12 @@
"links": [
{
"annotations": {
"Anatomy": {
"hypothalamus": true
},
"Confidence": {
"Medium": true
},
"Species": {
"10116": true
}
Expand All @@ -91,17 +97,23 @@
"volume": "137"
},
"evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
"key": "530e2b124518f599ab9adfcbfec36061805a001cc49a77bbac352a410d2df3d25665d1306aff075c24dce3797ce2be55552804c2497073a3cbebe2d8f2e5c24c",
"line": 78,
"relation": "positiveCorrelation",
"source": 2,
"key": "30c806c9625631a300e27d1704595f3ee23e12fcc9adbcae8ddb903580486ae767206c1949e2eecbaa4bce1c02007b230ff5a1ce61abb30a6eab9807dd792c14",
"line": 82,
"relation": "regulates",
"source": 4,
"subject": {
"modifier": "Activity"
},
"target": 1
},
{
"annotations": {
"Anatomy": {
"hypothalamus": true
},
"Confidence": {
"Medium": true
},
"Species": {
"10116": true
}
Expand All @@ -126,8 +138,8 @@
"volume": "137"
},
"evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
"key": "b01819c4cf1f287077b957b8ff920cda22d8a3bae6d6d899a979ff9ee10f376e09dd60e1da3f7ac49b36c45a8ba298fed64c1a918d512d8187ce221e5abb2432",
"line": 79,
"key": "feeec5f81a6c25cd7bc019e16dc15c12c5bc646b9a278a1fed5538102f153692334212a93aaccae7e4ccf1bd70213275fbc3748b6c1deda3617bfa585c59cb17",
"line": 83,
"object": {
"effect": {
"fromLoc": {
Expand All @@ -141,12 +153,53 @@
},
"modifier": "Translocation"
},
"relation": "regulates",
"source": 2,
"relation": "increases",
"source": 4,
"subject": {
"modifier": "Activity"
},
"target": 4
"target": 2
},
{
"annotations": {
"Anatomy": {
"hypothalamus": true
},
"Confidence": {
"Medium": true
},
"Species": {
"10116": true
}
},
"citation": {
"authors": [
"Chrousos GP",
"Lewis DB",
"Rice KC",
"Torpy DJ",
"Webster EL",
"Zachman EK"
],
"date": "1996-12-01",
"first": "Webster EL",
"last": "Chrousos GP",
"name": "Endocrinology",
"pages": "5747-50",
"reference": "8940412",
"title": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
"type": "PubMed",
"volume": "137"
},
"evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
"key": "530e2b124518f599ab9adfcbfec36061805a001cc49a77bbac352a410d2df3d25665d1306aff075c24dce3797ce2be55552804c2497073a3cbebe2d8f2e5c24c",
"line": 84,
"relation": "positiveCorrelation",
"source": 4,
"subject": {
"modifier": "Activity"
},
"target": 3
},
{
"annotations": {
Expand All @@ -156,6 +209,9 @@
"AssayType": {
"B": true
},
"Confidence": {
"Medium": true
},
"MeasurementRelation": {
"=": true
},
Expand Down Expand Up @@ -193,19 +249,25 @@
},
"evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
"key": "40a04dbabe438b8b8fafdfdc7bd04708f737b6736872da95889695d708e494d3cfc3126236b9304b4a8d0a9762dd91fc6ae16addbcbc4b19e65753f46ca79cb1",
"line": 91,
"line": 100,
"object": {
"modifier": "Activity"
},
"relation": "directlyIncreases",
"source": 2,
"source": 4,
"subject": {
"modifier": "Activity"
},
"target": 3
"target": 5
},
{
"annotations": {
"Anatomy": {
"hypothalamus": true
},
"Confidence": {
"Medium": true
},
"Species": {
"10116": true
}
Expand All @@ -231,16 +293,19 @@
},
"evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
"key": "0dcc3379615f5232a3fba98e915705dee2430979d68309bf900dc1e0a32fb0760202258b17b3d8fa37fec9eb563c5163707e3bef2b6aad3c4576675f26f3575e",
"line": 78,
"line": 84,
"object": {
"modifier": "Activity"
},
"relation": "positiveCorrelation",
"source": 1,
"target": 2
"source": 3,
"target": 4
},
{
"annotations": {
"Confidence": {
"High": true
},
"Species": {
"10116": true
}
Expand All @@ -266,9 +331,9 @@
},
"evidence": "These results raise the possibility that pyrrolopyrimidine compounds, such as antalarmin, which antagonize CRH at the level of its own receptor, have therapeutic potential in some forms of inflammation.",
"key": "e4b30e052332aa2e3a46c7499d492da0ea5606dbeb371da05994d7ee0160bd3a7c1df587500016b50ad7c7741053141c026969986cf73f62c0017c5e785406a3",
"line": 118,
"line": 129,
"relation": "negativeCorrelation",
"source": 1,
"source": 3,
"target": 0
},
{
Expand All @@ -279,6 +344,9 @@
"AssayType": {
"B": true
},
"Confidence": {
"Medium": true
},
"MeasurementRelation": {
"=": true
},
Expand Down Expand Up @@ -316,13 +384,61 @@
},
"evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
"key": "1d22d26c4f1fff94b2cf854e6398ca4615577c51747a04939e8fdec58ea987cf7fdbb028bfe3bc3268872d27e8d7f6a1772a598ad29992755114b358cd572cc8",
"line": 90,
"line": 99,
"object": {
"modifier": "Activity"
},
"relation": "directlyDecreases",
"source": 0,
"target": 2
"target": 4
},
{
"annotations": {
"Confidence": {
"Medium": true
},
"Species": {
"10116": true
}
},
"citation": {
"authors": [
"Chrousos GP",
"Lewis DB",
"Rice KC",
"Torpy DJ",
"Webster EL",
"Zachman EK"
],
"date": "1996-12-01",
"first": "Webster EL",
"last": "Chrousos GP",
"name": "Endocrinology",
"pages": "5747-50",
"reference": "8940412",
"title": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
"type": "PubMed",
"volume": "137"
},
"evidence": "Indeed, the compound significantly suppressed (XI-l-induced ACTH secretion to approximately the same extent as neutralizing polyclonal anti-CRH.",
"key": "d9203bbc9f15ca3f0805ec00cef4f5365685c66b9346aee5b76c143695364a4a5dd6423a3a688b7eef3c5379f1dbcbf863c349f04d281e6d017f533ced050f66",
"line": 136,
"object": {
"effect": {
"fromLoc": {
"name": "intracellular",
"namespace": "bel"
},
"toLoc": {
"name": "extracellular space",
"namespace": "bel"
}
},
"modifier": "Translocation"
},
"relation": "decreases",
"source": 0,
"target": 4
},
{
"annotations": {
Expand All @@ -332,6 +448,9 @@
"AssayType": {
"B": true
},
"Confidence": {
"Medium": true
},
"MeasurementRelation": {
"=": true
},
Expand Down Expand Up @@ -369,16 +488,19 @@
},
"evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
"key": "3f8dfcae335a7949fe86a4766cc69ba2dda3f8fc6fc0462731d2a07f69cb3bb41255bb00584cb62d1337b8e5003b350d01ee7cbf0f3d9a8d683922c35d776e7c",
"line": 92,
"line": 101,
"object": {
"modifier": "Activity"
},
"relation": "directlyDecreases",
"source": 0,
"target": 3
"target": 5
},
{
"annotations": {
"Confidence": {
"High": true
},
"Species": {
"10116": true
}
Expand All @@ -404,13 +526,31 @@
},
"evidence": "These results raise the possibility that pyrrolopyrimidine compounds, such as antalarmin, which antagonize CRH at the level of its own receptor, have therapeutic potential in some forms of inflammation.",
"key": "8bd32354bc87fa37ddeed0483100685d15a9543f75ef82c7a915e54c3d868407a05d94a7a1909ea76810e6822dc382a677c87725e0df0fd59da319ed59aaaa28",
"line": 118,
"line": 129,
"relation": "negativeCorrelation",
"source": 0,
"target": 1
"target": 3
},
{
"annotations": {
"Anatomy": {
"frontal cortex": true
},
"AssayType": {
"B": true
},
"Confidence": {
"Medium": true
},
"MeasurementRelation": {
"=": true
},
"MeasurementType": {
"Ki": true
},
"MeasurementUnits": {
"nM": true
},
"Species": {
"10116": true
}
Expand All @@ -434,25 +574,18 @@
"type": "PubMed",
"volume": "137"
},
"evidence": "Indeed, the compound significantly suppressed (XI-l-induced ACTH secretion to approximately the same extent as neutralizing polyclonal anti-CRH.",
"key": "a60c2d040e5283be39019e3254cb583b64ef33a0425ed25838991ce5737ed50ef9fbc4a8f24bd535280250345dfb6380154eac4b53978b36edabc50b65278ce6",
"line": 123,
"evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
"key": "4d7a8169711c6811ec5d29226fb8602474a3ae5b8a1295e09d65efb2adc2a231c0449e6f448eb62bb6e8d204f754279805f50944edc9f744996d35535894c11a",
"line": 117,
"object": {
"effect": {
"fromLoc": {
"name": "intracellular",
"namespace": "bel"
},
"toLoc": {
"name": "extracellular space",
"namespace": "bel"
}
},
"modifier": "Translocation"
"modifier": "Activity"
},
"relation": "decreases",
"source": 0,
"target": 4
"source": 6,
"subject": {
"modifier": "Activity"
},
"target": 5
}
],
"multigraph": true,
Expand All @@ -464,6 +597,20 @@
"name": "antalarmin",
"namespace": "CHEBI"
},
{
"bel": "a(MESH:\"Adrenocorticotropic Hormone\")",
"function": "Abundance",
"id": "cf288cf6a749a597d4cfbcac32847b7708bef0b64df47cdaf894dacc36f6089e3a00098a906596159e357b902b46650d7ddc70681b9845c08add7f727c45effe",
"name": "Adrenocorticotropic Hormone",
"namespace": "MESH"
},
{
"bel": "a(MESH:Glucocorticoids)",
"function": "Abundance",
"id": "abcbf36a76bd1cbe9767c48e56070ed109d78639742058342073bacbeebb78f939b84f3681d4ba456b5cf88d5a42546d4585c4f49018edd879895b9a027b0c52",
"name": "Glucocorticoids",
"namespace": "MESH"
},
{
"bel": "bp(GO:\"inflammatory response\")",
"function": "BiologicalProcess",
Expand All @@ -486,10 +633,10 @@
"namespace": "RGD"
},
{
"bel": "p(RGD:Pomc)",
"bel": "p(RGD:Crhr2)",
"function": "Protein",
"id": "d257157819e1bc033beeefdb183bc15f0ddfd4378f631158a4388b8ff59c3aaadb3c5a2d05af1026d2587a1849f30bb3cacbcde20d17fc3afc218804d1ca06ba",
"name": "Pomc",
"id": "f6f5b44c97267ad892c218b490edd04190a42bb9f48d34e46628687fb50fa974edf824165d30ca8ce603bca949290f57ec4d0a5b14552d9782b491e944d708a0",
"name": "Crhr2",
"namespace": "RGD"
}
]
Expand Down
Loading

0 comments on commit 2a32cc7

Please sign in to comment.